With the advent of advanced technology in performing diagnostics for lung cancer, an
incremental increase in the number of patients with oligometastatic disease is currently …

Progress in Radiotherapy for Regional and Oligometastatic Disease in 2017 -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

To analyze the impact of SBRT on systemic treatment-free survival in patients affected by
lung oligometastases. Inclusion criteria of the study were (a) KPS> 70,(b) 1–5 lung …

Background Patients with stage IV oligometastatic (≤ 3 sites) non–small-cell lung cancer
have a progression-free survival (PFS) and overall survival benefit when all sites of …

Lung oligometastases represent an intermediate state of cancer dissemination between
localized and widespread metastases. Stereotactic body radiation therapy (SBRT) has …

Published series suggest that, in carefully selected patients, long-term survival can be
obtained when a complete resection of the primary site and metastasis is achieved. It …

Background Patients with oligometastatic disease can potentially be cured by using an
ablative therapy for all active lesions. Stereotactic body radiotherapy (SBRT) is a non …

The management of patients with oligometastatic non-small cell lung cancer has undergone
significant improvement in recent years. The combination of increase in sensitivity of …

Background: Since the concept of oligometastases was proposed, several investigators
have suggested that aggressive local treatment of oligometastatic disease may be helpful in …

Highly active and durable systemic therapies such as targeted therapy and immunotherapy
can convert widespread metastatic disease into oligometastatic status, for which metastasis …